The Interplay between Gut Microbiota and Amavata: An Ayurvedic and Modern Perspective

Authors

  • A M Naveen Department of Swasthavritta and Yoga, KAHER’s Shri BMK Ayurveda Mahavidyalaya, Belagavi, Karnataka, India Author
  • Sholly Elizabeth Kuruvilla Department of Swasthavritta and Yoga, KAHER’s Shri BMK Ayurveda Mahavidyalaya, Belagavi, Karnataka, India Author
  • Ashok Patil Department of Swasthavritta and Yoga, BLDEA’s AVS Ayurveda Mahavidyalaya, Hospital and Research Centre, Vijayapura, Karnataka, India. Author

DOI:

https://doi.org/10.48165/IRJAY.2025.80903

Keywords:

Rheumatoid Arthritis, Ama, Mandagni, Pathya, Gut Health

Abstract

Amavata is a disorder characterized by the simultaneous vitiation of Ama (undigested toxic metabolic by-products) and Vata, which closely resembles rheumatoid arthritis (RA) in modern medicine. The disease manifests with pain, stiffness, swelling of joints, impaired mobility, and systemic features of inflammation. Contemporary research has increasingly highlighted the pivotal role of gut microbiota (GM) in immune modulation and the pathogenesis of autoimmune conditions, such as RA. This convergence opens a promising interface between classical Ayurvedic concepts and modern biomedical insights. From an Ayurvedic standpoint, deranged Agni (digestive fire) leads to the formation of Ama, which circulates through Srothas and accumulates in joints, triggering inflammation under the influence of vitiated Vata. Modern studies suggest that dysbiosis of GM contributes to increased intestinal permeability, altered immune tolerance, and systemic inflammation, which parallels the Ayurvedic description of Ama entering systemic circulation. Moreover, specific bacterial strains have been linked with RA pathogenesis, further strengthening the connection between gut health and joint disorders. Thus, the interplay between GM and Amavata illustrates a profound convergence of traditional Ayurvedic wisdom and modern biomedical science. Understanding this relationship offers novel integrative strategies for prevention and management, emphasizing the centrality of gut health in systemic well-being.

Downloads

Download data is not yet available.

References

Gupta SK, Thakar AB, Dudhamal TS, Nema A. Management of amavata (rheumatoid arthritis) with diet and virechanakarma. Ayu. 2015;36(4):413-5. doi: 10.4103/0974-8520.190688

Aswathy YS, Anandaraman PV. Therapeutic influence of some dietary articles on gut microbiota in the pathogenesis of rheumatoid arthritis (Amavata) - a review. Ayu. 2019;40(3):147-51. doi: 10.4103/ayu.ayu_192_19

Lekurwale PS, Pandey K, Yadaiah P. Management of Amavata with ‘Amrita Ghrita’: A clinical study. Ayu. 2010;1(4):430-5. doi: 10.4103/0974-8520.82033

Yadaiah P. Clinical panchakarma. 1st ed. Akola: Jaya Publication; 2005. p. 260.

Zhao T, Wei Y, Zhu Y, Xie Z, Hai Q, Li Z, Qin D. Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Front Immunol. 2022;13:1007165. doi: 10.3389/fimmu.2022.1007165

Tripathi B. Madhav nidana of madhavkar. Varanasi: Chaukhabha Sanskrit Sanshtan; 2006. p. 571.

Kabra DN, Bhatted SK. Management of amavata with panchakarma treatment - a case report. J Ayurveda Case Rep. 2023;6(3):119-24. doi: 10.4103/jacr.jacr_69_22

Kanojia A, Mishra AK, Pedhekar SR. Clinical and therapeutic approaches to amavata: An integrative review with special reference to rheumatoid arthritis. Int J Ayurvedic Herbal Med. 2025;15(2):4880-9.

Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18(10):591-602. doi: 10.1038/s41584-022-00827-y

Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L. The global burden of rheumatoid arthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316-22.

Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(3):633-9.

Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J. Incidence of rheumatoid arthritis in Sweden: A nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken). 2013;65(6):870-8.

Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA. The prevalence of rheumatoid arthritis: A systematic review of population-based studies. J Rheumatol. 2021;48(5):669-76.

Milind Y. Nadkar. API textbook of medicine. 8th ed. Mumbai: Association of Physicians of India; 2008. p. 291.

Vijayarakshita S, Kanthadatta S. Sanskrit. Vidyotini Hindi commentary noted by Sri Sudarshana Shastri. In: Upadhyaya YN, editor. Madhava nidana of madhavakara, amavata nidana, 25. Varanasi: Chaukhambha Sanskrita Series; 1970.

Basisht GK, Singh RH, Chandola H. Management of rheumatoid arthritis (Aamavata) using symbiohealth healthcare system. Ayu. 2012;33(4):466-74. doi: 10.4103/0974-8520.110513

Gao Y, Zhang Y, Liu X. Rheumatoid arthritis: Pathogenesis and therapeutic advances. MedComm. 2024;5(3):e509. doi: 10.1002/mco2.509

Vinay Mohan G, Dharmannavar G, Thipparapu V. Revisiting the drug analysis of amavata: Insights from gut microbiota and ayurvedic perspectives. World J Pharm Med Res. 2025;11(1):221-3.

Schrijver IA, Melief MJ, Tak PP, Hazenberg MP, Laman JD. Antigen presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthritis Rheum. 2000;43(10):2160-8.

Pianta A, Arvikar S, Strle K, Drouin EE, Wang Q, Costello CE, Steere AC. Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis. Arthritis Rheumatol. 2017;69(5):964-75. doi: 10.1002/art.40003

Flannigan KL, Denning TL. Segmented filamentous bacteria induced immune responses: A balancing act between host protection and autoimmunity. Immunology. 2018;154(4):537-46. doi: 10.1111/imm.12950

Wang Y, Yin Y, Chen X, Zhao Y, Wu Y, Li Y, Wang X, Chen H, Xiang C. Induction of intestinal Th17 cells by flagellins from segmented filamentous bacteria. Front Immunol. 2019;10:2750. doi: 10.3389/fimmu.2019.02750

Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, Narushima S, Suda W, Imaoka A, Setoyama H, Nagamori T, Ishikawa E, Shima T, Hara T, Kado S, Jinnohara T, Ohno H, Kondo T, Toyooka K, Watanabe E, Yokoyama S, Tokoro S, Mori H, Noguchi Y, Morita H, Ivanov II, Sugiyama T, Nuñez G, Camp JG, Hattori M, Umesaki Y, Honda K. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell. 2015;163(2):367-80. doi: 10.1016/j.cell.2015.08.058

Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011;332(6032):974-7. doi: 10.1126/science.1206095

Telesford KM, Yan W, Ochoa-Reparaz J, Pant A, Kircher C, Christy MA, Begum-Haque S, Kasper DL, Kasper LH. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and treg function. Gut Microbes. 2015;6(4):234-42. doi: 10.1080/19490976.2015.1056973

De Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: Mechanistic insights. Gut. 2022;71(5):1020-32. doi: 10.1136/gutjnl-2021-326789

Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823-36. doi: 10.1042/bcj20160510

Dong Y, Yao J, Deng Q, Li X, He Y, Ren X, Zheng Y, Song R, Zhong X, Ma J, Shan D, Lv F, Wang X, Yuan R, She G. Relationship between gut microbiota and rheumatoid arthritis: A bibliometric analysis. Front Immunol. 2023;14:1131933. doi: 10.3389/fimmu.2023.1131933

Alpizar-Rodriguez D, Lesker TR, Gronow A, Gilbert B, Raemy E, Lamacchia C, Gabay C, Finckh A, Strowig T. Prevotella copri in individuals at risk for rheumatoid arthritis. Ann Rheum Dis. 2019;78(5):590-3. doi: 10.1136/annrheumdis-2018-214514

Rooney CM, Mankia K, Mitra S, Moura IB, Emery P, Wilcox MH. Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis. Rheumatol (Oxford). 2021;60(7):3380-7. doi: 10.1093/rheumatology/keaa792

Gilbert BTP, Lamacchia C, Mongin D, Lauper K, Trunk E, Studer O, Courvoisier DS, Rubbert-Roth A, Kyburz D, Moeller B, Finckh A. Cohort profile: SCREEN-RA: Design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis. BMJ Open. 2021;11(7):e048409. doi: 10.1136/bmjopen-2020-048409

Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol. 2014;26(1):101-7. doi: 10.1097/bor.0000000000000008

Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3(1):4-14. doi: 10.4161/gmic.19320

Downloads

Published

2025-10-09

How to Cite

Naveen, A. M., Elizabeth Kuruvilla, S., & Patil, A. (2025). The Interplay between Gut Microbiota and Amavata: An Ayurvedic and Modern Perspective . International Research Journal of Ayurveda & Yoga, 8(9), 18-23. https://doi.org/10.48165/IRJAY.2025.80903